Intracellular degradation of histidine-rich glycoprotein mutants: Tokushima-1 and 2 mutants are degraded by different proteolytic systems

Journal of Biochemistry

Volumn 128, Issue 2, 2000, Pages 201-206

  Wakabayashi, Sadao ^a   Yoshida, Hidemasa ^a   Shigekiyo, Toshio ^b,c   Koide, Takehiko ^a  

^a UNIVERSITY OF HYOGO   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c TOKUSHIMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Deficiency; Histidine rich glycoprotein; Intracellular degradation; Proteasome

Indexed keywords

CYSTATIN; GLYCOPROTEIN; HISTIDINE; MUTANT PROTEIN; PROTEASOME; PROTEASOME INHIBITOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; GENE EXPRESSION; NONHUMAN; PROTEIN DEFICIENCY; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN SECRETION; PROTEIN STRUCTURE;

ANIMALIA; CRICETINAE;

EID: 0033864420     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jbchem.a022742     Document Type: Article

References (40)

1. Human serum proteins with a high affinity for carboxymethyl-cellulose II: Physicochemical and immunological characterization of a histidine-rich 3.8S α2-glycoprotein (CM protein I)
2. Amino acid sequence of human histidine-rich glycoprotein derived from the nucleotide sequence of its cDNA
3. Histidine-rich glycoprotein is evolutionarily related to the cystatin superfamily: Presence of two cystatin domains in the N-terminal region
4. Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein
5. Interaction of histidine-rich glycoprotein with fibrinogen and fibrin
6. Histidine-rich glycoprotein binds to human IgG and C1q and inhibits the formation of insoluble immune complexes
7. Regulation of complement functional efficiency by histidine-rich glycoprotein
8. Antifibrinolytic versus profibrinolytic functions of histidine-rich glycoprotein
9. Interaction of heparin with histidine-rich glycoprotein and with antithrombin III
10. Histidine-rich glycoprotein modulation of the anticoagulant activity of heparin. Evidence for a mechanism involving competition with both antithrombin and thrombin for heparin binding
11. Histidine-rich glycoprotein inhibits the anti-thrombin activity of heparin cofactor II in the presence of heparin and dermatan sulfate
12. Modulation of protein C inhibitor activity by histidine-rich glycoprotein and platelet factor 4: Role of zinc and calcium ions in the heparin-neutralizing ability of histidine-rich glycoprotein
13. Serum histidine-rich glycoprotein during pregnancy and hormone treatment
14. The fibrinolytic system in the newborn: Role of histidine-rich glycoprotein
15. Familial elevation of plasma histidine-rich glycoprotein in a family with thrombophilia
16. Familial association of high levels of histidine-rich glycoprotein and plasminogen activator inhibitor-1 with venous thromboembolism
17. High levels of histidine-rich glycoprotein and thrombotic diathesis. Report of two unrelated families
18. Congenital histidine-rich glycoprotein deficiency
19. HRG Tokushima: Molecular and cellular characterization of histidine-rich glycoprotein (HRG) deficiency
20. Structural characterization of the gene for human histidine-rich glycoprotein, reinvestigation of the 5'-terminal region of cDNA and a search for the liver specific promoter in the gene
21. A new case of hereditary histidine-rich glycoprotein deficiency with familial thrombophilia
22. Histidine-rich glycoprotein Tokushima 2
23. Expression and release of the a and b subunits for human coagulation factor XIII in baby hamster kidney (BHK) cells
24. High-efficiency transformation of mammalian cells by plasmid DNA
25. A filter immunoassay for detection of protein secreting cell colonies
26. ER quality control:The cytoplasmic connection
27. 1-antitrypsin Z, in the endoplasmic reticulum requires proteasome activity
28. Intracellular degradation of secretion defect-type mutants of antithrombin is inhibited by proteasomal inhibitors
29. Factor XII Tenri, a novel cross-reacting material negative factor XII deficiency, occurs through a proteasome-mediated degradation
30. Lactacystin, proteasome function, and cell fate
31. A giant protease with potential to substitute for some functions of proteasome
32. Purification, substrate specificity, and classification of tripeptidyl peptidase III
33. Characterization and cloning of tripeptidyl peptidase II from the fruit fly, Drosophila melanogaster
34. Characterization of two naturally occurring mutations in the second epidermal growth facto-like domain of factor VII
35. Isolation and characterization of two 20S proteasomes from the endoplasmic reticulum of rat liver microsomes
36. Prediction of the secondary structure of proteins from their amino acid sequence
37. The 2.0 Å X-ray crystal structure of chicken egg white cystatin, and its possible mode of interaction with cysteine proteinases
38. Antithrombin-Gly 424 Arg: A novel point mutation responsible for type I antithrombin deficiency and neonatal thrombosis
39. Induced and spontaneous mutation at Ser-202 of carboxypeptidase E. Effect on enzyme expression, activity and intracellular routing
40. A single amino acid change in the acetylcholinesterase-like domain of thyroglobulin causes congenital goiter with hypothyroidism in the cog/cog mouse: A model of human endoplasmic reticulum storage disease